Trials / Recruiting
RecruitingNCT04166266
National Cohort of Patients Co-infected With Hepatitis B and Delta Viruses
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 800 (estimated)
- Sponsor
- ANRS, Emerging Infectious Diseases · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a multicentre observational study with prospective and retrospective data collection and retrospective data collection and biological collection from patients with HBV/HDV co-infection.
Detailed description
This is an observatory for patients co-infected with hepatitis B and Delta viruses. Patients will be monitored according to the usual recommendations, depending on their status: * Patients who have never received specific treatment for hepatitis Delta (untreated or receiving treatment with peginterferon alpha 2a alone) will be monitored according to current recommendations, once every 6 months; * Patients treated or having been treated with a specific hepatitis Delta treatment will be monitored according to the compassionate access protocol or according to the recommendations of the AMM during treatment and according to routine follow-up after the end of treatment. Participation in research entails the following additional procedures for patients, for each line of treatment, where applicable: * Samples for the biobank, * Self-administered questionnaires. In addition, as sub-studies are planned on sub-groups of patients, these sub-studies may involve additional constraints/interventions
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood draw for the laboratory assessment | Blood sampling for the biobank and, in addition, as sub-studies are planned on sub-groups of patients, additional blood samples are planned for the patients in these sub-studies. |
Timeline
- Start date
- 2020-02-19
- Primary completion
- 2027-12-31
- Completion
- 2028-06-30
- First posted
- 2019-11-18
- Last updated
- 2025-02-05
Locations
38 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04166266. Inclusion in this directory is not an endorsement.